PI

P3 Health Partners Inc.

PIIIHealthcareNASDAQ

Medical Care Facilities

PriceMA150MA200
Loading chart…
End-of-day data · ScananceOpen live chart on TradingView ↗
Indicator snapshot · Today
Premium
Today's indicator reading is locked

Free plan shows historical signals only. Upgrade to see this ticker's current MA150, MA200, RSI, and MACD readings.

Upgrade to see today →
Financials · Annual
Revenue
$1.46B
-2.8% YoY
Net Income
-$147.9M
-8.9% YoY
EBITDA
-$181.9M
+8.0% YoY
Free Cash Flow
-$124.3M

Scan Results

Daily timeframe
1 recent day hidden. Fresh signals are a Premium featureUpgrade →
DateIndicatorDetails
Sep 3 RSI OversoldRSI 29.0, below 30, stock may be oversold
Sep 2 RSI OversoldRSI 14.1, below 30, stock may be oversold
About P3 Health Partners Inc.

Headquartered within the healthcare sector, P3 Health Partners Inc. focuses on Medical Care Facilities services and products. P3 Health Partners Inc., a patient-centered and physician-led population health management company, provides superior care services in the United States. The $1.87B market capitalization puts PIII squarely in small-cap range for its industry. It operates clinics and wellness centers.

Where PIII stands vs its 150-day and 200-day moving averages

As of the September 3, 2026 close, PIII finished 36.57% above its 150-day moving average ($6.89) and 50.80% above its 200-day moving average ($6.24). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.

Is PIII overbought or oversold?

At the September 3, 2026 close, PIII's RSI(14) was 29.0, in oversold territory (below 30). The MACD histogram was negative, so short-term momentum leaned bearish at that close. These readings are historical, refresh daily after market close, and are not investment advice.

Key stats
Market Cap$1.87B
Fwd P/E-44.52
EPS$-33.01
Beta1.62
52W Change+6.5%
ROE-192.6%
Analysis

P3 Health Partners Inc. carries $130.7M in total debt against $21.3M in cash reserves — debt is roughly 6.1x the cash position. Managing this leverage effectively will be important for long-term financial stability. The company is burning cash, with free cash flow at -$124.3M. This typically occurs when a company is investing aggressively in growth, but sustained cash burn can strain the balance sheet. Return on equity stands at -192.6%, which is negative for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. Revenue has grown from $1.05B (2022) to $1.46B (2025), reflecting a 39% increase over the period.

A beta of 1.62 means PIII is more volatile than average. Investors should be prepared for wider price swings relative to broader indices. Debt significantly exceeds cash reserves, which means the company's financial flexibility could be constrained during economic downturns. The company is burning cash at the operating level, which is not unusual for growth-phase companies but adds risk if it persists. No single metric tells the full story. Reviewing PIII's risk profile alongside its fundamentals and technical indicators provides a more complete picture.

Links
More Healthcare stocks
Browse all stocks →
Not financial advice. Scanance shows end-of-day technical indicators (not real-time prices) for information only. Results can be wrong; past performance does not guarantee future results.PrivacyTerms